Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The regulatory landscape is evolving: in February 2026, HHS announced that approximately 14 previously restricted peptides including BPC-157, TB-500, CJC-1295, Ipamorelin, and Sermorelin are expected to return to Category 1 compounding status
Each optimization therapy can be used as a standalone boost or integrated strategically within a larger health optimization plan that includes DEXA scans, lab analysis, nutrition, and medical oversight
Licensed Peptides provides the CJC-1295 (No DAC) + Ipamorelin 10 mg blend exclusively for research and investigational use
its about making informed choices that fit your lifestyle
Baserga et al, 1997)
Ipamorelin's pharmacokinetic profile reflects its design as a selective growth hormone secretagogue achieving rapid, pulsatile GH release without the off-target hormonal effects that limit other GHRPs
US$ 26.88
US$ 21.40
US$ 29.02
US$ 27.93
US$ 22.18
US$ 22.12
